Cancer Overview

Overview

Cancer encompasses more than 100 distinct malignant diseases, each arising from genetic and epigenetic alterations that disrupt normal cellular regulation. These changes enable cells to proliferate without the usual checks, evade programmed cell death (apoptosis), and acquire the ability to invade surrounding tissues and metastasize to distant organs. While any tissue can develop cancer, the most common types include breast, lung, colorectal, prostate, and skin (melanoma) cancers. Early detection through screening and awareness of warning signs—such as unexplained weight loss, persistent pain, or changes in moles—greatly improves treatment outcomes. If you notice any concerning symptoms, seek professional medical evaluation promptly; early diagnosis can be lifesaving.

History/Background

The concept of cancer dates back to ancient Egypt, where papyri described tumors and surgical removal. The term “cancer” originates from the Greek physician Hippocrates, who used “carcinos” and “carcinoma” to describe crab-like tumors. In the 19th century, Rudolf Virchow introduced the idea that cancer arises from cells, laying the groundwork for modern pathology. The discovery of DNA structure in 1953 and subsequent identification of oncogenes and tumor suppressor genes in the 1970s transformed cancer from a purely morphological disease to a molecular one. Landmark milestones include the development of the first chemotherapy agent (nitrogen mustard) in the 1940s, the introduction of tamoxifen for breast cancer in the 1970s, and the approval of immunotherapy checkpoint inhibitors in the 2010s, which harness the immune system to target tumors.

Key Information

- Etiology: Cancer results from a combination of genetic mutations, environmental exposures (e.g., tobacco, UV radiation, carcinogenic chemicals), infectious agents (HPV, Hepatitis B/C), and lifestyle factors (diet, obesity). - Pathophysiology: Hallmarks include sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, replicative immortality, angiogenesis, and metastasis. - Diagnosis: Relies on imaging (CT, MRI, PET), histopathology, molecular profiling, and biomarkers such as PSA, CA-125, and PD-L1. - Treatment modalities: Surgery, radiation therapy, chemotherapy, targeted therapy (e.g., tyrosine kinase inhibitors), hormonal therapy, and immunotherapy. Multimodal approaches are often required for optimal control. - Survival trends: Global cancer mortality has declined in high‑income countries due to early detection and advanced therapies, yet incidence continues to rise with aging populations and lifestyle changes. - Prevention: Up to 30‑50% of cancers are preventable through vaccination (HPV, Hepatitis B), tobacco cessation, sun protection, healthy diet, and regular screening.

If you have a family history of cancer, persistent symptoms, or risk factors, consult a healthcare professional for personalized screening recommendations.

Significance

Cancer remains a leading cause of death worldwide, accounting for nearly 10 million deaths annually. Its impact extends beyond health, influencing economies, social structures, and public policy. Advances in precision medicine have shifted treatment from one-size-fits-all to genotype‑guided therapies, improving survival and quality of life. Research into the tumor microenvironment and immune checkpoint pathways has opened new therapeutic frontiers, offering hope for previously untreatable malignancies. Moreover, cancer research drives innovations in genomics, bioinformatics, and drug development that benefit broader biomedical science. Understanding cancer’s biology is essential for developing effective prevention strategies, reducing health disparities, and ultimately moving toward the global goal of reducing premature mortality from non‑communicable diseases.